Now showing items 1-1 of 1
Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain
(Springer Nature, 2022)
Introduction The effectiveness, safety, and cost-effectiveness of the use of Souvenaid for Alzheimer’s disease (AD) have been previously evidenced. To complete the economic analysis, there is a need to assess whether ...